{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:27:36Z","timestamp":1754144856173,"version":"3.41.2"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007351","name":"Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["UBACyT 20020170100283BA"],"award-info":[{"award-number":["UBACyT 20020170100283BA"]}],"id":[{"id":"10.13039\/501100007351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2019-3717-2633"],"award-info":[{"award-number":["PICT-2019-3717-2633"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10072-025-08137-3","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T07:47:09Z","timestamp":1742888829000},"page":"4071-4072","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AChR-blocking antibodies and complement system dynamics: evaluating their interplay and clinical implications in myasthenia gravis"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9147-496X","authenticated-orcid":false,"given":"Florencia","family":"Aguirre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2657-788X","authenticated-orcid":false,"given":"Mariano E.","family":"Justo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Cialdella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9371-216X","authenticated-orcid":false,"given":"Mariela L.","family":"Paz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"8137_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-025-08070-5","author":"HY Seok","year":"2025","unstructured":"Seok HY, Eun MY (2025) Acetylcholine receptor blocking antibodies in myasthenia gravis: reevaluating their role in disease severity and mechanisms. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-025-08070-5. Online ahead of print","journal-title":"Neurol Sci"},{"key":"8137_CR2","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s10072-024-07889-8","volume":"46","author":"F Aguirre","year":"2024","unstructured":"Aguirre F, Justo ME, Cialdella L, Paz ML (2024) AChR-blocking antibodies and complement system dynamics: evaluating their interplay and clinical implications in myasthenia Gravis. Neurol Sci 46:1827\u20131832. https:\/\/doi.org\/10.1007\/s10072-024-07889-8","journal-title":"Neurol Sci"},{"key":"8137_CR3","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1212\/WNL.33.10.1316","volume":"33","author":"UA Besinger","year":"1983","unstructured":"Besinger UA, Toyka KV, H\u00f6mberg M et al (1983) Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology 33:1316\u20131316. https:\/\/doi.org\/10.1212\/WNL.33.10.1316","journal-title":"Neurology"},{"key":"8137_CR4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1749-6632.1987.tb51321.x","volume":"505","author":"FM Howard","year":"1987","unstructured":"Howard FM, Lennon VA, Finley J et al (1987) Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis a. Ann N Y Acad Sci 505:526\u2013538. https:\/\/doi.org\/10.1111\/j.1749-6632.1987.tb51321.x","journal-title":"Ann N Y Acad Sci"},{"key":"8137_CR5","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s10072-015-2236-8","volume":"36","author":"SY Kang","year":"2015","unstructured":"Kang SY, Oh JH, Song SK et al (2015) Both binding and blocking antibodies correlate with disease severity in myasthenia gravis. Neurol Sci 36:1167\u20131171. https:\/\/doi.org\/10.1007\/s10072-015-2236-8","journal-title":"Neurol Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08137-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08137-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08137-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T05:28:22Z","timestamp":1752643702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08137-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["8137"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08137-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}